Grey Wolf Therapeutics secures $49M series B from Pfizer Venture Investments and EarlyBird VC
24 January 2023
24 January 2023
Total investments received (USD): 150.58M
Round value (USD): 49M
Company: Grey Wolf Therapeutics
Related deals
Mestag Therapeutics raised $40 million in a round led by investors including SV Health Investors, Johnson & Johnson Innovation and Forbion.
Investments
02 March 2026
Engitix raised $25m in a Series A extension from Netherton Investments
Investments
09 December 2025
Cellular Origins raises a $40 million Series A round led by Johnson & Johnson, joined by Highland Europe, BGF, NYBC Ventures, and TTP Group
Investments
04 December 2025
Relation Tx raised $26m from insiders NVentures, DCVC, and Magnetic Ventures.
Investments
02 December 2025
EpilepsyGTx raised $33m in Series A funding from XGEN Venture and the British Business Bank.
Investments
02 December 2025
Belgium
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Portugal
Spain